Paper201618
Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.
Kusiak JW and 2 others. J Biol Chem, 1978. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Purification and properties of the two major isozymes of alpha-galactosidase from human placenta. Papers, record 201618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/201618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purification and properties of the two major isozymes of alpha-galactosidase from human placenta.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Galactosidases | Major topic |
| Isoenzymes | Major topic |
| Placenta | Major topic |
| alpha-Galactosidase | Major topic |
| Female | |
| Humans | |
| Kinetics | |
| Methods | |
| Molecular Weight | |
| Pregnancy |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40725422 | Comparative Evaluation of AAV8 and AAV9 Gene Therapy in Fabry Knockout (Gla-/y) and Symptomatic (G3STg/+Gla-/y) Murine Models. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40725422 | PubMed |
| 36959353 | Optimizing human α-galactosidase for treatment of Fabry disease. | Sci Rep | 2023 | https://conductscience.org/library/papers/36959353 | PubMed |
| 33809185 | Intra-Laboratory Validation of Alpha-Galactosidase Activity Measurement in Dietary Supplements. | Molecules | 2021 | https://conductscience.org/library/papers/33809185 | PubMed |
| 32995357 | In Vitro and In Vivo Amenability to Migalastat in Fabry Disease. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/32995357 | PubMed |
| 30038331 | Urine-derived cells: a promising diagnostic tool in Fabry disease patients. | Sci Rep | 2018 | https://conductscience.org/library/papers/30038331 | PubMed |
| 28545388 | Chemical and structural characterization of α-N-acetylgalactosaminidase I and II from starfish, asterina amurensis. | BMC Biochem | 2017 | https://conductscience.org/library/papers/28545388 | PubMed |
| 25719393 | Carboxyl-terminal truncations alter the activity of the human α-galactosidase A. | PLoS One | 2015 | https://conductscience.org/library/papers/25719393 | PubMed |
| 23691056 | Dysregulated autophagy contributes to podocyte damage in Fabry's disease. | PLoS One | 2013 | https://conductscience.org/library/papers/23691056 | PubMed |
| 23118528 | Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy. | Drug Des Devel Ther | 2012 | https://conductscience.org/library/papers/23118528 | PubMed |
| 21747096 | Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice. | J Lipid Res | 2011 | https://conductscience.org/library/papers/21747096 | PubMed |
| 20526001 | Use of lissamine rhodamine ceramide trihexoside as a functional assay for alpha-galactosidase A in intact cells. | J Lipid Res | 2010 | https://conductscience.org/library/papers/20526001 | PubMed |
| 20398385 | Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer. | J Biomed Sci | 2010 | https://conductscience.org/library/papers/20398385 | PubMed |
| 20385825 | Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20385825 | PubMed |
| 18698230 | Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone. | Pharmacogenet Genomics | 2008 | https://conductscience.org/library/papers/18698230 | PubMed |
| 17644384 | Establishment and characterization of Fabry disease endothelial cells with an extended lifespan. | Mol Genet Metab | 2007 | https://conductscience.org/library/papers/17644384 | PubMed |
| 17532296 | Screening for pharmacological chaperones in Fabry disease. | Biochem Biophys Res Commun | 2007 | https://conductscience.org/library/papers/17532296 | PubMed |
| 17188539 | Cellular and tissue distribution of intravenously administered agalsidase alfa. | Mol Genet Metab | 2007 | https://conductscience.org/library/papers/17188539 | PubMed |
| 17105746 | Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. | Brain | 2007 | https://conductscience.org/library/papers/17105746 | PubMed |
| 16347214 | Production, Purification, and Characterization of alpha-Galactosidase from Monascus pilosus. | Appl Environ Microbiol | 1986 | https://conductscience.org/library/papers/16347214 | PubMed |
| 16151903 | High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease. | J Inherit Metab Dis | 2005 | https://conductscience.org/library/papers/16151903 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/201618
GET https://conductscience.org/api/papers/v1/201618/cited_by?page=2